Global Market for Quantum Technologies (Quantum Computing, Cryptography, Communications, Sensors, Batteries) 2024-2035 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Market for Quantum Technologies (Quantum Computing, Cryptography, Communications, Sensors, Batteries) 2024-2035”... Read more.
Supermicro Announces Proposed Public Offering of Common Stock
SAN JOSE, Calif.–(BUSINESS WIRE)–Super Micro Computer, Inc. (“Supermicro” or the “Company”) (Nasdaq: SMCI) today announced the launch of a proposed... Read more.
Tilak Healthcare Strengthens Its Leadership Team
– Anne-Aurélie Epis de Fleurian, Director of Public Affairs and Market Access – Benoit Gueugnon, Chief Administrative and Financial Officer –... Read more.
PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis
Company also elevates Jeff O’Donnell, Sr. to executive chairman and moves polymer processing in-house to new local manufacturing facility as it reaches critical... Read more.
AngloGold Ashanti Releases Preliminary Unaudited Condensed Consolidated Financial Statements as of and for the Six Months and the Year Ended 31 December 2023
Announces Annual General Meeting Date and Restatement of Previously Issued Financial Statements LONDON & DENVER & JOHANNESBURG–(BUSINESS WIRE)–AngloGold... Read more.
Pembina Pipeline Corporation Receives Canadian Competition Bureau Approval for the Proposed Acquisition of Enbridge’s Interest in Alliance/Aux Sable
CALGARY, Alberta–(BUSINESS WIRE)–Pembina Pipeline Corporation (“Pembina” or the “Company”) (TSX: PPL; NYSE: PBA) is pleased to... Read more.
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease
Second biotechnology company to potentially out-license novel compounds from Enveric’s portfolio of assets with possible significant milestone payments and royalties... Read more.
B Capital Closes Opportunities Fund II at $750 Million
Venture Fund Focused on Later-Stage Growth Investments in Top-Performing, Companies Across Technology, Healthcare and Climate Tech NEW YORK–(BUSINESS WIRE)–B... Read more.
Leading Squamous Cell Carcinoma Practitioners Publish Consensus Guidelines Integrating DecisionDx®-SCC into a Clinical Workflow to Improve Decision-Making Regarding the Use of Adjuvant Radiation Therapy
The consensus guidelines were drafted by a multidisciplinary panel of radiation oncologists and dermatologists/Mohs micrographic surgeons with expertise in cutaneous... Read more.
Dr. Reddy’s Laboratories launches Versavo® (bevacizumab) in the UK
Versavo® (bevacizumab) is indicated for the treatment of several types of cancers including metastatic colorectal cancer, advanced non-squamous non-small cell lung... Read more.